Cargando…

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia

OBJECTIVES: Natural killer (NK) cells are an attractive source of cells for an ‘off the shelf’ cellular therapy because of their innate capacity to target malignant cells, and ability to be transferred between donors and patients. However, since not all NK cells are equally effective at targeting ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foley, Bree, Ta, Clara, Barnes, Samantha, de Jong, Emma, Nguyen, Michelle, Cheung, Laurence C, Buzzai, Anthony, Wagner, Teagan, Wylie, Ben, Fernandez, Sonia, Cruickshank, Mark, Endersby, Raelene, Kees, Ursula, Waithman, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365579/ https://www.ncbi.nlm.nih.gov/pubmed/32695339 http://dx.doi.org/10.1002/cti2.1151

Ejemplares similares

Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens
por: Wylie, Ben, et al.
Publicado: (2019)

CD8(+)XCR1(neg) Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors
por: Wylie, Ben, et al.
Publicado: (2019)

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
por: Audsley, Katherine M., et al.
Publicado: (2021)

Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes
por: Buzzai, Anthony C., et al.
Publicado: (2020)

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
por: Barnes, Samantha A., et al.
Publicado: (2022)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
por: Sandri, Sara, et al.
Publicado: (2017)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities
por: López Villar, Elena, et al.
Publicado: (2014)

Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy
por: Karppinen, Santeri, et al.
Publicado: (2019)

The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy
por: Grobbelaar, Carle, et al.
Publicado: (2019)

Natural Killer Cell Lymphoblastic Leukaemia/Lymphoma: Case Report and Review of the Recent Literature
por: Sedick, Qanita, et al.
Publicado: (2017)

Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study
por: Hahn, Seung Min, et al.
Publicado: (2022)

Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia
por: Weeks, Robert J, et al.
Publicado: (2010)

HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?
por: Ab Rahman, Syaza, et al.
Publicado: (2022)

Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
por: Toscan, Cara E., et al.
Publicado: (2020)

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission.
por: Pizzolo, G., et al.
Publicado: (1988)

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2015)

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
por: Venn, Nicola C., et al.
Publicado: (2022)

Superior mediastinal syndrome in paediatric B-cell acute lymphoblastic leukaemia: a case report
por: Rahat-Ul-Ain,, et al.
Publicado: (2022)

The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
por: Chulián, Salvador, et al.
Publicado: (2023)

Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia
por: Samuels, Amy L, et al.
Publicado: (2010)

Overweight and obesity management strategies in survivors of paediatric acute lymphoblastic leukaemia: a systematic review protocol
por: Ladhani, Salma, et al.
Publicado: (2018)

Blinatumomab as bridging therapy in paediatric B‐cell acute lymphoblastic leukaemia complicated by invasive fungal disease
por: Yeoh, Daniel K., et al.
Publicado: (2022)

Paediatric pre‐B acute lymphoblastic leukaemia‐derived exosomes regulate immune function in human T cells
por: Gholipour, Elham, et al.
Publicado: (2022)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
por: Beesley, A H, et al.
Publicado: (2010)

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
por: Beesley, A H, et al.
Publicado: (2009)

T lymphoblastic leukaemia and the central nervous system.
por: Lilleyman, J. S., et al.
Publicado: (1981)

Long survival in childhood lymphoblastic leukaemia.
por: Chessells, J. M., et al.
Publicado: (1987)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
por: Da Costa, D, et al.
Publicado: (2013)

Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia
por: Lu, Y, et al.
Publicado: (2014)

Low spontaneous apoptosis index at diagnosis predicts a high-risk phenotype in paediatric acute lymphoblastic leukaemia
por: Singh, Ankita, et al.
Publicado: (2018)

An information-theory analysis of DNA methylation identifies converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia
por: Koldobskiy, Michael A., et al.
Publicado: (2021)

Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia
por: Huang, Qingsheng, et al.
Publicado: (2021)

Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia
por: Ben Hassine, Khalil, et al.
Publicado: (2021)

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
por: Beesley, A H, et al.
Publicado: (2006)

Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia – preliminary report
por: Ulińska, Edyta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jveei6m0vj9mts8c7tl8s5pgf8